81
A Multi-dose Study of ARC-520 in Patients With Hepatitis B ‘e’ Antigen (HBeAg) Negative, Chronic Hepatitis B Virus (HBV) Infection
Condition(s):Hepatitis BLast Updated:April 16, 2019Terminated
Hide Studies Not Open or Pending
Condition(s):Hepatitis BLast Updated:April 16, 2019Terminated
Condition(s):Acute Respiratory Infections; Acute RhinosinusitisLast Updated:December 28, 2012Completed
Condition(s):HIV Infections; SinusitisLast Updated:October 28, 2021Withdrawn
Condition(s):Adenocarcinoma of the Oesophagus; Adenocarcinoma of the Oesophago-gastric Junction; Oesophageal Tumours; Junctional Tumours; Oesophageal CancerLast Updated:September 30, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.